Childhood porphyrias

Iftikhar Ahmed1

  • 1Department of Dermatology, Mayo Clinic, Rochester, Minn 55905, USA. ahmed.iftikhar2@mayo.edu

Mayo Clinic Proceedings
|August 14, 2002
PubMed

Insights

Childhood porphyrias are rare inherited metabolic disorders affecting heme synthesis. These complex genetic conditions cause photosensitivity and skin issues, with limited treatment options but a low mortality rate.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Childhood porphyrias are uncommon inherited metabolic disorders.
  • They stem from enzyme deficiencies in the heme biosynthetic pathway.
  • Global incidence remains largely unknown, with complex inheritance patterns.

Purpose of the Study:

  • To summarize the key aspects of childhood porphyrias.
  • To highlight their genetic basis, clinical presentation, and management challenges.

Main Methods:

  • Review of existing literature on childhood porphyrias.
  • Analysis of genetic heterogeneity and phenotypic variability.
  • Summary of current therapeutic and preventive strategies.

Main Results:

  • Childhood porphyrias exhibit significant phenotypic variability due to genetic heterogeneity.
  • Common clinical manifestations include photosensitivity and characteristic skin lesions.
  • Treatment primarily focuses on symptomatic and preventive care.

Conclusions:

  • Childhood porphyrias are complex genetic disorders with variable courses.
  • Despite limited therapies, mortality is rare.
  • Further research into incidence and management is warranted.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...